94 related articles

LifeSciBench is a life science AI benchmark developed by 173 biotech and pharma scientists, featuring 750 expert tasks across seven research workflows.

Nobel Chemistry laureate and AlphaFold lead John Jumper leaves Google DeepMind for Anthropic, signaling an intensifying AI talent war and reshaping the AI for Science landscape.

June 20 AI Brief: OpenAI Codex adds cross-host session handoff, Claude Code fixes 3% user quota bug, AlphaFold lead John Jumper leaves DeepMind for Anthropic, EU bets on 400B-param open-source model.

Deep dive into Anjney Midha, the key figure behind a16z's AMP fund, covering investments in Anthropic, Mistral, and Black Forest Labs, and his Outputmaxxing philosophy.

Why is AI racing ahead in coding but struggling in biology? This article analyzes the structural infrastructure gap and explores how to build Agent-friendly scientific data platforms.

Anthropic's latest research shows Claude Opus 4.7 matches or surpasses dedicated NMR spectroscopy software. Explore the technical significance, drug discovery implications, and future of AI science tools.

Deep dive into DeepSeek v4's Tool Confusion problem and its deterministic fix. Repair Logic dramatically improves open-source model tool call accuracy, outperforming Claude Opus 4.7 in practice.
OpenAI Model Disproves 80-Year-Old Erd…
OpenAI's AI model found a counterexample disproving an 80-year-old Erdős conjecture. Learn about the human-AI collaboration process, mathematical significance, and AI's breakthrough in pure math.

Alpha-gal Syndrome is a real meat allergy caused by tick bites, but social media conflates it with genetic engineering conspiracies. This article examines the science, epidemiology, and logical flaws in conspiracy narratives.

OpenAI for Science division officially split up, with its head departing. Deep analysis of OpenAI's strategy to decentralize science research across teams and its implications for the AGI roadmap.

OpenAI launches GPT-Rosalind, its first frontier AI model for biology, drug discovery, and translational medicine. A deep dive into its capabilities, trusted access deployment, and industry impact.

A social science researcher shares hands-on experience with Google's latest AI research tools, analyzing Google's leadership in AI-accelerated science and future multi-disciplinary expansion.

Google officially releases Gemini for Science, an experimental AI toolkit for researchers covering hypothesis exploration, large-scale validation, and literature interpretation to accelerate scientific discovery.

Explore how the NVIDIA RTX PRO 4500 Blackwell workstation GPU accelerates genomic analysis and protein folding prediction, and its critical role in precision medicine and drug discovery.

Anthropic applies AI to biodefense — from early epidemic warnings and rapid vaccine R&D to threat assessment — exploring AI's critical role in global public health security.
Where Did the Antimatter Go? The Most …
The Big Bang should have produced equal matter and antimatter, yet antimatter nearly vanished. Explore antimatter's discovery, CERN experiments, production challenges, and the matter-antimatter asymmetry puzzle.
Tech FrontiersOpenAI CEO Sam Altman announces a general-purpose AI model has solved a major open math problem. We analyze this milestone, the leap from specialized to general AI, and its implications for science.
Industry InsightsSam Altman shares OpenAI's three strategic directions: AGI accelerating research, partnering with YC to empower startups, and building personal AGI assistants. A deep analysis of OpenAI's complete AGI deployment path.
Industry InsightsA simple tweet sparks wide discussion: What do you most want AI to solve? From healthcare to education equity and scientific research, exploring the shift from technology-driven to demand-driven AI.
Tech FrontiersOpenAI launches Rosalind Biodefense, offering GPT-Rosalind to government agencies to accelerate pathogen surveillance, vaccine R&D, and pandemic preparedness using AI.